InvestorsHub Logo
Followers 66
Posts 11443
Boards Moderated 0
Alias Born 10/20/2009

Re: 1hb post# 292404

Friday, 03/24/2017 3:47:59 PM

Friday, March 24, 2017 3:47:59 PM

Post# of 345746
More than mice?

Peregrine Pharmaceuticals Announces Initiation of an Investigator-Sponsored Trial Combining Its Immunotherapy Bavituximab and Ipilimumab (Yervoy®) in Advanced Melanoma


http://ir.peregrineinc.com/releasedetail.cfm?ReleaseID=841892

Interesting thoughts...

A test kit partner would be fabulous about now. I suppose we need a larger test population before we get that though...

wook

Best of $RESULTS for Humanity, FDA Approval(s), Partner(s) Production, Imaging and MOST IMPORTANTLY!!!
Research.
Always looking deeper. RIP Dr. Thorpe

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News